Literature DB >> 11877260

BCR ligation reprograms B cells for migration to the T zone and B-cell follicle sequentially.

Montserrat Casamayor-Pallejà1, Paul Mondière, Claire Verschelde, Chantal Bella, Thierry Defrance.   

Abstract

We have studied the impact of B-cell receptor (BCR) or CD40 ligation on the in vitro chemotactic response of tonsillar B cells to 4 chemokines: stromal cell-derived factor (SDF)-1alpha, macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and B-cell-attracting chemokine (BCA)-1. In the tonsil, SDF-1 and MIP-3alpha are both expressed in the crypt epithelium, while MIP-3beta is found in the T zone and BCA-1 in the follicles. Resting virgin and memory B cells display a similar chemotaxis pattern, and they both have the potential to migrate in vitro to all 4 chemokines studied. This pattern of responsiveness is strongly modified by a surrogate antigen (Ag) but is not altered by CD40 ligand. We report here that surrogate Ag induces a profound and sustained suppression of the response to the crypt chemokines SDF-1alpha and MIP-3alpha, while it exacerbates the migratory response to MIP-3beta. The effect of surrogate Ag on the response to BCA-1 is biphasic: After an initial phase of suppression, chemotaxis toward BCA-1 is strongly up-regulated. Our results suggest that Ag is primarily responsible for reprogramming the B-cell chemotaxis responsiveness during the humoral response. We propose that it initiates an ordered change of the chemotaxis machinery allowing Ag-activated B cells to relocate in the T zone and B-cell follicles sequentially.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877260     DOI: 10.1182/blood.v99.6.1913

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Pathway-selective suppression of chemokine receptor signaling in B cells by LPS through downregulation of PLC-β2.

Authors:  Aiko-Konno Shirakawa; Fang Liao; Hongwei H Zhang; Michael N Hedrick; Satya P Singh; Dianqing Wu; Joshua M Farber
Journal:  Cell Mol Immunol       Date:  2010-09-27       Impact factor: 11.530

Review 2.  CCR6 as a possible therapeutic target in psoriasis.

Authors:  Michael N Hedrick; Anke S Lonsdorf; Sam T Hwang; Joshua M Farber
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

3.  Corruption of human follicular B-lymphocyte trafficking by a B-cell superantigen.

Authors:  Gwenoline Borhis; Muriel Viau; Gamal Badr; Yolande Richard; Moncef Zouali
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

4.  HGAL inhibits lymphoma dissemination by interacting with multiple cytoskeletal proteins.

Authors:  Xiaoyu Jiang; XiaoQing Lu; Andrew J Gentles; Dekuang Zhao; Seth A Wander; Yu Zhang; Yasodha Natkunam; Joyce Slingerland; Isildinha M Reis; Brian Rabinovich; Midhat H Abdulreda; Vincent T Moy; Izidore S Lossos
Journal:  Blood Adv       Date:  2021-12-14

5.  B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.

Authors:  Maite P Quiroga; Kumudha Balakrishnan; Antonina V Kurtova; Mariela Sivina; Michael J Keating; William G Wierda; Varsha Gandhi; Jan A Burger
Journal:  Blood       Date:  2009-06-02       Impact factor: 22.113

Review 6.  Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues.

Authors:  Jacob D Estes
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

7.  Exodus-1 (CCL20): evidence for the participation of this chemokine in spontaneous labor at term, preterm labor, and intrauterine infection.

Authors:  Neil Hamill; Roberto Romero; Francesca Gotsch; Juan Pedro Kusanovic; Sam Edwin; Offer Erez; Nandor Gabor Than; Pooja Mittal; Jimmy Espinoza; Lara A Friel; Edi Vaisbuch; Shali Mazaki-Tovi; Sonia S Hassan
Journal:  J Perinat Med       Date:  2008       Impact factor: 1.901

8.  S1P3 confers differential S1P-induced migration by autoreactive and non-autoreactive immature B cells and is required for normal B-cell development.

Authors:  Erin E Donovan; Roberta Pelanda; Raul M Torres
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

9.  ZAP-70 promotes the infiltration of malignant B-lymphocytes into the bone marrow by enhancing signaling and migration after CXCR4 stimulation.

Authors:  Eva Calpe; Noelia Purroy; Cecilia Carpio; Pau Abrisqueta; Júlia Carabia; Carles Palacio; Josep Castellví; Marta Crespo; Francesc Bosch
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

10.  CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytes.

Authors:  Anna Corcione; Elisa Ferretti; Maria Bertolotto; Franco Fais; Lizzia Raffaghello; Andrea Gregorio; Claudya Tenca; Luciano Ottonello; Claudio Gambini; Glaucia Furtado; Sergio Lira; Vito Pistoia
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.